ID27741A - Larutan teriparatide yang distabilkan - Google Patents
Larutan teriparatide yang distabilkanInfo
- Publication number
- ID27741A ID27741A IDW20001318A ID20001318A ID27741A ID 27741 A ID27741 A ID 27741A ID W20001318 A IDW20001318 A ID W20001318A ID 20001318 A ID20001318 A ID 20001318A ID 27741 A ID27741 A ID 27741A
- Authority
- ID
- Indonesia
- Prior art keywords
- solidide
- solided
- stabilized
- stabilized solided
- solided solidide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6907597P | 1997-12-09 | 1997-12-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID27741A true ID27741A (id) | 2001-04-26 |
Family
ID=22086574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW20001318A ID27741A (id) | 1997-12-09 | 1998-12-08 | Larutan teriparatide yang distabilkan |
Country Status (32)
Country | Link |
---|---|
EP (2) | EP1417972B2 (da) |
JP (1) | JP4405666B2 (da) |
KR (1) | KR100482703B1 (da) |
CN (1) | CN1198644C (da) |
AR (1) | AR018526A1 (da) |
AT (1) | ATE260113T1 (da) |
AU (1) | AU759726B2 (da) |
BR (1) | BR9813463A (da) |
CA (1) | CA2314313C (da) |
CY (1) | CY1114000T1 (da) |
CZ (1) | CZ302401B6 (da) |
DE (1) | DE69821872T2 (da) |
DK (2) | DK0920873T3 (da) |
EA (1) | EA004761B1 (da) |
EG (1) | EG23675A (da) |
ES (2) | ES2215268T3 (da) |
HK (1) | HK1021798A1 (da) |
HU (1) | HU230784B1 (da) |
ID (1) | ID27741A (da) |
IL (1) | IL136662A (da) |
MY (1) | MY120063A (da) |
NO (1) | NO327302B1 (da) |
NZ (1) | NZ505222A (da) |
PE (1) | PE20000001A1 (da) |
PL (1) | PL194268B1 (da) |
PT (2) | PT1417972E (da) |
SK (1) | SK288203B6 (da) |
TR (1) | TR200002134T2 (da) |
TW (1) | TW570811B (da) |
UA (1) | UA72884C2 (da) |
WO (1) | WO1999029337A1 (da) |
ZA (1) | ZA9811127B (da) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL140984A0 (en) * | 1998-07-23 | 2002-02-10 | Lilly Co Eli | Fsh and fsh variant formulations, products and methods |
US20030166525A1 (en) | 1998-07-23 | 2003-09-04 | Hoffmann James Arthur | FSH Formulation |
AR033639A1 (es) | 1998-08-19 | 2004-01-07 | Lilly Co Eli | Uso de hormonas paratiroideas para preparar medicamentos para reducir el riesgo de fracturas oseas vertebrales o no vertebrales en seres humanos con riesgo de padecer o que padecen osteoporosis |
US7022674B2 (en) | 1999-12-16 | 2006-04-04 | Eli Lilly And Company | Polypeptide compositions with improved stability |
CA2380423A1 (en) * | 2000-05-17 | 2001-11-22 | Bionebraska, Inc. | Peptide pharmaceutical formulations |
JP2004513069A (ja) * | 2000-05-19 | 2004-04-30 | レストラゲン,インコーポレイテッド | ペプチド医薬処方 |
US20040156835A1 (en) * | 2001-05-30 | 2004-08-12 | Taiji Imoto | Protein preparation |
US20040242489A1 (en) * | 2001-11-05 | 2004-12-02 | Mitlak Bruce Howard | Method for improving stability of a bone-connecting implant |
EP1767213A3 (en) * | 2001-11-05 | 2007-04-25 | Eli Lilly & Company | Method for improving stability of a bone-connecting implant |
US8088734B2 (en) | 2003-01-21 | 2012-01-03 | Unigene Laboratories Inc. | Oral delivery of peptides |
MXPA05010635A (es) | 2003-04-02 | 2005-12-12 | Ares Trading Sa | Formulaciones farmaceuticas liquidas de hormona estimulante de foliculos y hormona luteinizante junto con un surfactante no ionico. |
ES2414705T3 (es) | 2003-06-20 | 2013-07-22 | Ares Trading S.A. | Formulaciones liofilizadas de FSH/LH |
US7329725B1 (en) | 2003-10-29 | 2008-02-12 | Nastech Pharmaceutical Company Inc. | Phage displayed Trp cage ligands |
CN104826116A (zh) | 2003-11-20 | 2015-08-12 | 诺沃挪第克公司 | 对于生产和用于注射装置中是最佳的含有丙二醇的肽制剂 |
CA2547343C (en) | 2003-12-23 | 2013-05-14 | Infinity Pharmaceuticals, Inc. | Analogs of benzoquinone-containing ansamycins for the treatment of cancer |
US20060046962A1 (en) | 2004-08-25 | 2006-03-02 | Aegis Therapeutics Llc | Absorption enhancers for drug administration |
US8268791B2 (en) | 2004-08-25 | 2012-09-18 | Aegis Therapeutics, Llc. | Alkylglycoside compositions for drug administration |
US8642564B2 (en) | 2004-08-25 | 2014-02-04 | Aegis Therapeutics, Llc | Compositions for drug administration |
US9895444B2 (en) | 2004-08-25 | 2018-02-20 | Aegis Therapeutics, Llc | Compositions for drug administration |
US9114069B2 (en) | 2004-08-25 | 2015-08-25 | Aegis Therapeutics, Llc | Antibacterial compositions for drug administration |
EP1789075A4 (en) * | 2004-08-25 | 2009-07-01 | Uab Research Foundation | ABSORPTION ENHANCER FOR DRUG ADMINISTRATION |
US20140162965A1 (en) | 2004-08-25 | 2014-06-12 | Aegis Therapeutics, Inc. | Compositions for oral drug administration |
KR100700869B1 (ko) * | 2005-06-03 | 2007-03-29 | 재단법인 목암생명공학연구소 | Pth, 완충제 및 안정제를 포함하는 안정한 pth조성물 |
EP1945245A2 (en) | 2005-11-10 | 2008-07-23 | The Board of Control of Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
US8226949B2 (en) | 2006-06-23 | 2012-07-24 | Aegis Therapeutics Llc | Stabilizing alkylglycoside compositions and methods thereof |
US8148333B2 (en) * | 2006-10-03 | 2012-04-03 | Radius Health, Inc. | Stable composition comprising a PTHrP analogue |
USRE49444E1 (en) | 2006-10-03 | 2023-03-07 | Radius Health, Inc. | Method of treating osteoporosis comprising administration of PTHrP analog |
US7803770B2 (en) | 2006-10-03 | 2010-09-28 | Radius Health, Inc. | Method of treating osteoporosis comprising administration of PTHrP analog |
EP1958618A1 (de) * | 2007-02-15 | 2008-08-20 | Octapharma AG | Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren |
MX2009010808A (es) * | 2007-04-12 | 2009-10-29 | Infinity Discovery Inc | Formulaciones de ansamicina de hidroquinona. |
US20080299228A1 (en) * | 2007-05-29 | 2008-12-04 | Alan Gerald Harris | Topical compositions comprising a macromolecule and methods of using same |
MX2009013886A (es) | 2007-06-25 | 2010-01-27 | Amgen Inc | Composiciones de agentes de aglutinacion especifica al factor de crecimiento de los hepatocitos. |
EP2271347B1 (en) | 2008-03-28 | 2016-05-11 | Hale Biopharma Ventures, Llc | Administration of benzodiazepine compositions |
US8895546B2 (en) | 2009-03-27 | 2014-11-25 | Hale Biopharma Ventures, Llc | Administration of benzodiazepine compositions |
CN102245021B (zh) | 2008-10-15 | 2014-09-17 | 无限药品公司 | 安莎霉素氢醌组合物 |
US8440631B2 (en) | 2008-12-22 | 2013-05-14 | Aegis Therapeutics, Llc | Compositions for drug administration |
ES2663322T3 (es) * | 2009-09-09 | 2018-04-12 | Asahi Kasei Pharma Corporation | Agente terapéutico/profiláctico que contiene PTH para la osteoporosis, caracterizado porque la PTH se administra una vez por semana en una dosis unitaria de 200 unidades |
CA2782640A1 (en) | 2009-12-07 | 2011-06-16 | Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
CN102731643A (zh) * | 2012-06-26 | 2012-10-17 | 深圳翰宇药业股份有限公司 | 一种治疗骨质疏松多肽的制备方法 |
CN103301058A (zh) * | 2013-06-17 | 2013-09-18 | 深圳翰宇药业股份有限公司 | 一种特立帕肽注射用组合物及其制备方法和制剂 |
CN108024540B (zh) | 2015-04-29 | 2021-09-17 | 雷迪厄斯制药公司 | 用于治疗癌症的方法 |
CN106309358A (zh) * | 2015-06-29 | 2017-01-11 | 成都金凯生物技术有限公司 | 含有人甲状旁腺激素的药物组合物及其制备方法与用途 |
JP6634758B2 (ja) * | 2015-09-25 | 2020-01-22 | ニプロ株式会社 | 液体組成物及び凍結乾燥製剤 |
MY196308A (en) | 2016-03-01 | 2023-03-24 | Ascendis Pharma Bone Diseases As | PTH Prodrugs |
CN117257922A (zh) | 2016-09-29 | 2023-12-22 | 阿森迪斯药物骨疾病股份有限公司 | 具有低峰-谷比的pth化合物 |
RS64440B1 (sr) | 2016-09-29 | 2023-09-29 | Ascendis Pharma Bone Diseases As | Režim doziranja za pth jedinjenje sa kontrolisanim oslobađanjem |
EP3565542B1 (en) | 2017-01-05 | 2024-04-10 | Radius Pharmaceuticals, Inc. | Polymorphic forms of rad1901-2hcl |
US10996208B2 (en) | 2017-04-28 | 2021-05-04 | Radius Health, Inc. | Abaloparatide formulations and methods of testing, storing, modifying, and using same |
SG11202000940XA (en) | 2017-08-24 | 2020-02-27 | Novo Nordisk As | Glp-1 compositions and uses thereof |
CN111032073A (zh) * | 2017-09-22 | 2020-04-17 | 旭化成制药株式会社 | 药物动力学和/或安全性优异的含有特立帕肽的液态药物组合物 |
JP2019060866A (ja) * | 2017-09-22 | 2019-04-18 | 旭化成ファーマ株式会社 | 液状医薬組成物の体内動態を予測する方法 |
CN116898955A (zh) * | 2017-09-22 | 2023-10-20 | 旭化成制药株式会社 | 稳定性优异的含有特立帕肽的液态药物组合物 |
CN108159404B (zh) * | 2018-01-05 | 2019-08-27 | 北京博康健基因科技有限公司 | 重组人甲状旁腺激素制剂及其制备方法 |
WO2019220654A1 (ja) * | 2018-05-17 | 2019-11-21 | 旭化成ファーマ株式会社 | N-ホルミルピぺリジン含有量が低減されている、及び/又は、凍結乾燥ケーキの崩潰又は収縮が抑制されている、製剤 |
BR112021014581A2 (pt) * | 2019-02-11 | 2021-12-14 | Ascendis Pharma Bone Diseases As | Formulações farmacêuticas líquidas de conjugados de pth |
CN112439054B (zh) * | 2019-08-28 | 2023-05-16 | 深圳翰宇药业股份有限公司 | 一种特立帕肽缓释凝胶注射液及其制备方法 |
CA3165359A1 (en) | 2020-02-18 | 2021-07-22 | Dorthe Kot Engelund | Glp-1 compositions and uses thereof |
EP4110370A4 (en) * | 2020-03-30 | 2023-06-07 | Sichuan Luzhou Buchang Bio-Pharmaceutical Co., Ltd. | FORMULATIONS OF HUMAN PARATHYROID HORMONE (PTH) AND METHODS OF MANUFACTURE THEREOF |
CN113967249A (zh) * | 2021-12-10 | 2022-01-25 | 深圳先进技术研究院 | 甲状旁腺激素在制备治疗男性抑郁症的药物或保健品中的应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6360940A (ja) * | 1986-09-01 | 1988-03-17 | Toyo Jozo Co Ltd | 白内障の予防または治療剤 |
JP2505812B2 (ja) * | 1987-07-10 | 1996-06-12 | 旭化成工業株式会社 | h―PTH(1―34)凍結乾燥組成物 |
US5059587A (en) * | 1987-08-03 | 1991-10-22 | Toyo Jozo Company, Ltd. | Physiologically active peptide composition for nasal administration |
DE3935738A1 (de) * | 1989-10-27 | 1991-05-08 | Forssmann Wolf Georg | Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff |
GB9020544D0 (en) † | 1990-09-20 | 1990-10-31 | Sandoz Ltd | Improvements in or relating to organic compounds |
WO1993011785A1 (en) * | 1991-12-09 | 1993-06-24 | Asahi Kasei Kogyo Kabushiki Kaisha | Stabilized parathyroid hormone composition |
KR100291620B1 (ko) | 1992-09-29 | 2001-10-24 | 추후제출 | 부갑상선호르몬의활성단편의폐를통한전달방법 |
IT1255723B (it) † | 1992-10-09 | 1995-11-13 | Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione | |
US5496801A (en) * | 1993-12-23 | 1996-03-05 | Allelix Biopharmaceuticals Inc. | Parathyroid hormone formulation |
DE19538687A1 (de) † | 1995-10-17 | 1997-04-24 | Boehringer Mannheim Gmbh | Stabile pharmazeutische Darreichungsformen enthaltend Parathormon |
-
1998
- 1998-12-04 MY MYPI98005507A patent/MY120063A/en unknown
- 1998-12-04 ZA ZA9811127A patent/ZA9811127B/xx unknown
- 1998-12-07 ES ES98123225T patent/ES2215268T3/es not_active Expired - Lifetime
- 1998-12-07 DK DK98123225T patent/DK0920873T3/da active
- 1998-12-07 ES ES03104219T patent/ES2405994T5/es not_active Expired - Lifetime
- 1998-12-07 AR ARP980106213A patent/AR018526A1/es active IP Right Grant
- 1998-12-07 PT PT3104219T patent/PT1417972E/pt unknown
- 1998-12-07 DK DK03104219.5T patent/DK1417972T4/da active
- 1998-12-07 EG EG151498A patent/EG23675A/xx active
- 1998-12-07 PT PT98123225T patent/PT920873E/pt unknown
- 1998-12-07 EP EP03104219.5A patent/EP1417972B2/en not_active Expired - Lifetime
- 1998-12-07 DE DE69821872T patent/DE69821872T2/de not_active Revoked
- 1998-12-07 EP EP98123225A patent/EP0920873B1/en not_active Revoked
- 1998-12-07 AT AT98123225T patent/ATE260113T1/de not_active IP Right Cessation
- 1998-12-08 CZ CZ20002115A patent/CZ302401B6/cs not_active IP Right Cessation
- 1998-12-08 WO PCT/US1998/026043 patent/WO1999029337A1/en active IP Right Grant
- 1998-12-08 EA EA200000629A patent/EA004761B1/ru not_active IP Right Cessation
- 1998-12-08 CN CNB988119641A patent/CN1198644C/zh not_active Ceased
- 1998-12-08 HU HU0004447A patent/HU230784B1/hu unknown
- 1998-12-08 AU AU17177/99A patent/AU759726B2/en not_active Expired
- 1998-12-08 JP JP2000524006A patent/JP4405666B2/ja not_active Expired - Lifetime
- 1998-12-08 ID IDW20001318A patent/ID27741A/id unknown
- 1998-12-08 UA UA2000074034A patent/UA72884C2/uk unknown
- 1998-12-08 BR BR9813463-9A patent/BR9813463A/pt not_active Application Discontinuation
- 1998-12-08 NZ NZ505222A patent/NZ505222A/en not_active IP Right Cessation
- 1998-12-08 PL PL98340902A patent/PL194268B1/pl unknown
- 1998-12-08 IL IL13666298A patent/IL136662A/en not_active IP Right Cessation
- 1998-12-08 KR KR10-2000-7006211A patent/KR100482703B1/ko not_active IP Right Cessation
- 1998-12-08 CA CA002314313A patent/CA2314313C/en not_active Expired - Lifetime
- 1998-12-08 TR TR2000/02134T patent/TR200002134T2/xx unknown
- 1998-12-08 SK SK1532-2000A patent/SK288203B6/sk not_active IP Right Cessation
- 1998-12-09 TW TW087120429A patent/TW570811B/zh not_active IP Right Cessation
- 1998-12-09 PE PE1998001200A patent/PE20000001A1/es not_active IP Right Cessation
-
1999
- 1999-12-09 HK HK99105809A patent/HK1021798A1/xx not_active IP Right Cessation
-
2000
- 2000-06-08 NO NO20002945A patent/NO327302B1/no not_active IP Right Cessation
-
2013
- 2013-05-17 CY CY20131100405T patent/CY1114000T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID27741A (id) | Larutan teriparatide yang distabilkan | |
ID28110A (id) | Surfaktan alkilbenzenasulfonat yang disempurnakan | |
NO20003131D0 (no) | Krystallinsk teriparatid | |
ID22500A (id) | Turunan sulfonamida | |
ID24430A (id) | Turunan-turunan benzamidina | |
DE69818489D1 (de) | Schnappbefestigung | |
DE59814181D1 (de) | Multifunktionstastschalter | |
ID24529A (id) | Turunan-turunan 9-oksima eritromisin | |
DE69814990D1 (de) | Einspritzventil | |
FI973171A0 (fi) | Foerfarande foer drift av arbetsfartyg | |
NO983733D0 (no) | Ryggsekk | |
NO20002555D0 (no) | Skjøt | |
ID20897A (id) | Susunan penutup-rapat | |
FI973961A0 (fi) | Lyft- och belastningsanordning foer en valsstapel i en kalander | |
ATA187898A (de) | Schliesszylinder | |
DE69729748D1 (de) | Kunststein | |
DE69737716D1 (de) | Kunststein | |
FIU970474U0 (fi) | Suojakatos | |
IT243063Y1 (it) | Fissaggio per ombrellone | |
FI974242A0 (fi) | Formframstaellning av plywoodprofil i kontinuerlig drift | |
FI972751A (fi) | Ääntä hajottava soladiffusorirakenne | |
UA1655S (uk) | Навіс | |
FI3092U1 (fi) | Lompakko matkapuhelinkotelo | |
KR980000790U (ko) | 힘돌 | |
FI980265A (fi) | Suihkujauhin |